QDEL Quidel Corporation Stock Quote

QDEL [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	6.93	EPS (ttm)	18.59	Insider Own	1.50%	Shs Outstand	42.22M	Perf Week	4.57%
Market Cap	5.33B	Forward P/E	10.00	EPS next Y	12.88	Insider Trans	-6.52%	Shs Float	37.09M	Perf Month	-9.78%
Income	810.30M	PEG	0.96	EPS next Q	5.11	Inst Own	82.50%	Short Float	10.94%	Perf Quarter	-34.94%
Sales	1.66B	P/S	3.21	EPS this Y	971.80%	Inst Trans	-4.73%	Short Ratio	4.58	Perf Half Y	-52.39%
Book/sh	31.57	P/B	4.08	EPS next Y	-50.96%	ROA	64.10%	Target Price	224.00	Perf Year	17.30%
Cash/sh	11.84	P/C	10.88	EPS next 5Y	7.20%	ROE	95.40%	52W Range	106.12 - 306.72	Perf YTD	-28.29%
Dividend	-	P/FCF	9.44	EPS past 5Y	154.30%	ROI	61.30%	52W High	-60.33%	Beta	0.06
Dividend %	-	Quick Ratio	3.10	Sales past 5Y	53.30%	Gross Margin	81.20%	52W Low	14.66%	ATR	7.04
Employees	1370	Current Ratio	3.40	Sales Q/Q	431.70%	Oper. Margin	63.20%	RSI (14)	35.29	Volatility	4.58% 4.63%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	1435.10%	Profit Margin	48.80%	Rel Volume	1.03	Prev Close	128.83
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 18 AMC	Payout	0.00%	Avg Volume	886.13K	Price	121.68
Recom	2.50	SMA20	-5.97%	SMA50	-23.27%	SMA200	-40.91%	Volume	329,315	Change	-5.55%

Jan-22-21

Upgrade

Raymond James

Mkt Perform → Outperform

$250

May-12-20

Downgrade

JP Morgan

Neutral → Underweight

$120 → $158

Mar-26-20

Downgrade

Barclays

Overweight → Equal Weight

$90

Oct-23-18

Resumed

Raymond James

Strong Buy

$80

Mar-08-18

Upgrade

Raymond James

Outperform → Strong Buy

Jan-22-18

Reiterated

Barclays

Overweight

$50 → $60

Jan-04-18

Upgrade

CL King

Neutral → Buy

Sep-19-17

Upgrade

Piper Jaffray

Neutral → Overweight

Jul-18-17

Upgrade

William Blair

Mkt Perform → Outperform

Jul-18-17

Upgrade

Canaccord Genuity

Hold → Buy

$25 → $42

Apr-25-17

Reiterated

Canaccord Genuity

Hold

$24 → $24.50

Feb-17-17

Initiated

CL King

Neutral

Dec-16-16

Downgrade

Piper Jaffray

Overweight → Neutral

Jun-13-16

Upgrade

Raymond James

Mkt Perform → Outperform

Feb-18-16

Reiterated

Barclays

Overweight

$28 → $22

Feb-09-16

Downgrade

Canaccord Genuity

Buy → Hold

$22 → $18

Jan-08-16

Reiterated

Canaccord Genuity

Buy

$25 → $22

Dec-14-15

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-02-15

Initiated

Barclays

Overweight

$28

Jul-31-13

Reiterated

Canaccord Genuity

Buy

$30 → $35

Apr-14-21 05:45PM	Quidel (QDEL) Stock Moves -0.28%: What You Should Know Zacks
05:04PM	Is QDEL Stock A Buy or Sell? Insider Monkey
Apr-13-21 08:00AM	Quidel Corporation Partners With the Bay Area Lyme Foundation to Heighten Public Awareness of Lyme Disease News Direct
08:00AM	Quidel Corporation Partners With the Bay Area Lyme Foundation to Heighten Public Awareness of Lyme Disease Business Wire
Apr-08-21 05:50PM	Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know Zacks
Apr-07-21 10:15PM	Over-the-counter, 15-minute COVID-19 tests are coming to a store near you and this is how much theyll cost MarketWatch
Apr-05-21 08:00AM	Start of Lyme Disease Season Provides Heightened Risks for Americans Wanting to Go Outdoors After a Year of COVID-19 Restrictions News Direct
08:00AM	Start of Lyme Disease Season Provides Heightened Risks for Americans Wanting to Go Outdoors After a Year of COVID-19 Restrictions Business Wire
Apr-01-21 08:02PM	Quidels Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing Business Wire
07:30PM	Quidel Partners With San Diego Padres Organization for COVID-19 Testing Business Wire
05:45PM	Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know Zacks
02:46PM	Quidel issued first emergency use authorization by FDA for a COVID-19 antigen test Yahoo Finance Video
08:55AM	Abbott-Quidel Rapid COVID-19 Test Cleared by FDA TheStreet.com
Mar-31-21 11:30PM	Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing Business Wire
11:00PM	Quidels QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing Business Wire
Mar-30-21 06:40AM	These 3 Stocks Will Make You Rethink Your Portfolio Motley Fool
Mar-29-21 10:04AM	A Look Into Healthcare Sector Value Stocks Benzinga
Mar-26-21 05:45PM	Quidel (QDEL) Gains But Lags Market: What You Should Know Zacks
12:12PM	Covid Fatigue Threatens to Derail Once Relevant Quidel InvestorPlace
Mar-25-21 04:49PM	Top Healthcare Stocks for April 2021 Investopedia
02:50PM	Top Stocks for April 2021 Investopedia
Mar-22-21 11:11AM	Analysts Say Buy the Pullback in These 3 Stocks TipRanks
Mar-20-21 06:45AM	4 Reasons I Couldn't Resist Buying This Ridiculously Cheap Coronavirus Stock Motley Fool
Mar-18-21 06:00PM	Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing Business Wire -5.69%
Mar-16-21 05:50PM	Quidel (QDEL) Dips More Than Broader Markets: What You Should Know Zacks
Mar-15-21 12:44PM	Alger Small Cap Focus: Quidel Corp. (QDEL) is Among Our Top Detractors Insider Monkey
Mar-13-21 02:27AM	Quidel Corporation (NASDAQ:QDEL) Analysts Just Cut Their EPS Forecasts Substantially Simply Wall St.
Mar-12-21 03:33AM	I Ran A Stock Scan For Earnings Growth And Quidel (NASDAQ:QDEL) Passed With Ease Simply Wall St.
Mar-10-21 04:06PM	Why Quidel Stock Suddenly Plunged This Afternoon Motley Fool -16.60%
Mar-08-21 09:51AM	5 Value Stocks In The Healthcare Sector Benzinga
Mar-01-21 11:51AM	Quidel Receives Emergency Use Authorization for QuickVue® At-Home COVID-19 Test Business Wire
09:49AM	A Look Into Healthcare Sector Value Stocks Benzinga
Feb-22-21 05:00PM	Why Quidel Stock Got Crushed on Monday Motley Fool -10.43%
04:10PM	Quidel to Present at Upcoming Conferences Business Wire
Feb-20-21 11:05AM	Which Stocks Could Win if the U.S. Requires COVID Tests for Domestic Flights? Motley Fool
Feb-19-21 02:45PM	Why Quidel Corporation Stock Is Plunging Today Motley Fool -13.09%
07:25AM	The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko Benzinga
06:05AM	Why Investors Didn't Leap for Joy After Quidel's Strong Q4 Performance Motley Fool
01:00AM	Quidel Corp (QDEL) Q4 2020 Earnings Call Transcript Motley Fool
Feb-18-21 04:22PM	Quidel: Q4 Earnings Insights Benzinga
04:10PM	Quidel Reports Fourth Quarter and Full Year 2020 Financial Results Business Wire
03:15PM	Quidel Corp. to Host Earnings Call ACCESSWIRE
Feb-12-21 11:16AM	Meridian Bioscience Shows Market Leadership With Jump To 91 RS Rating Investor's Business Daily
Feb-10-21 11:30AM	UPDATE 2-Qiagen is interested in organic growth and acquisitions - CEO Reuters
Feb-09-21 05:45PM	Quidel (QDEL) Gains As Market Dips: What You Should Know Zacks
12:10PM	Why Quidel (QDEL) is Poised to Beat Earnings Estimates Again Zacks
Feb-08-21 04:32PM	Quidel Weighs Qiagen Deal as Medical M&A Quickens Bloomberg
02:43PM	Quidel Profit Rose 6 Quarters In Row, Soaring 726% Last Quarter Investor's Business Daily
Feb-04-21 05:05PM	Align Technology's Composite Rating Soars To 98 Investor's Business Daily
12:51PM	Quidel (QDEL) to Report Q4 Earnings: What's in the Offing? Zacks
Feb-03-21 05:45PM	Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know Zacks
04:10PM	Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19 Business Wire
Feb-01-21 04:41PM	Quidel Stock Passes Relative Strength Rating Test With Upgrade To 83 Investor's Business Daily
01:03PM	Is Quidel Corp (QDEL) Stock a Buy For 2021? Insider Monkey
Jan-28-21 04:10PM	Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021 Business Wire
Jan-27-21 05:45PM	Quidel (QDEL) Stock Moves -0.87%: What You Should Know Zacks
Jan-26-21 04:42AM	Is Quidel Corporation's (NASDAQ:QDEL) Latest Stock Performance A Reflection Of Its Financial Health? Simply Wall St. -5.16%
Jan-25-21 12:05PM	Top Ranked Growth Stocks to Buy for January 25th Zacks
Jan-22-21 09:38AM	Boston Scientific (BSX) Enhances Core Business With Buyout Zacks +6.92%
Jan-20-21 06:18AM	The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic Zacks +5.64%
Jan-19-21 05:11PM	Quidel Flashes Improved Relative Price Strength Investor's Business Daily
01:13PM	Quidel Earns Composite Rating Upgrade To 97 Investor's Business Daily
10:30AM	Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays Zacks
09:56AM	Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens Zacks
Jan-18-21 10:08AM	PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing Zacks
07:59AM	4 Momentum Stocks to Explore the Lucrative Driehaus Strategy Zacks
Jan-17-21 04:18PM	Too Late To Buy Quidel (QDEL)? Insider Monkey
Jan-14-21 05:45PM	Quidel (QDEL) Gains As Market Dips: What You Should Know Zacks
12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Quidel (QDEL) Zacks
11:51AM	The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics Zacks
11:40AM	QDEL vs. RMD: Which Stock Is the Better Value Option? Zacks
Jan-13-21 10:18AM	Neogen (NEOG) Launches Dairy Toxin Detection Test Reveal Q+ Zacks
Jan-12-21 09:09AM	Baxter (BAX) Inks Sterile Manufacturing Agreement With Novavax Zacks
Jan-08-21 10:16AM	Stryker (SYK) Buys OrthoSensor to Grow in Sensor Technology Zacks
Jan-07-21 02:15PM	Quidel Announces Preliminary Revenue for Fourth Quarter 2020; Will Present Virtually at 39th Annual J.P. Morgan Healthcare Conference Business Wire
10:25AM	Top Ranked Momentum Stocks to Buy for January 7th Zacks
07:15AM	Are These Medical Stocks Cruising Toward Bullish Gains? Here's A Key Sign Investor's Business Daily
Jan-05-21 05:14PM	Quidel Begins To Show Strength, Approaches Benchmark Investor's Business Daily +5.03%
11:30AM	Is Quidel (QDEL) Outperforming Other Medical Stocks This Year? Zacks
10:02AM	Top Ranked Momentum Stocks to Buy for January 5th Zacks
09:22AM	Allscripts (MDRX) Completes Sale of CarePort Health Business Zacks
08:04AM	4 Top Momentum Stocks Powered by Driehaus Strategy Zacks
Dec-24-20 05:50PM	Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know Zacks
10:36AM	Here's Why Hold Strategy is Apt for Magellan (MGLN) Stock Zacks
Dec-23-20 01:30PM	Quidel Receives Emergency Use Authorization for Moderately Complex Solana® SARS Molecular Test for COVID-19 Diagnosis Business Wire
Dec-21-20 03:08PM	Why Quidel Corporation Stock Is Jumping Today Motley Fool +8.42%
02:25PM	Quidel Rapid Antigen Test for COVID-19 Wins Authorization Motley Fool
10:01AM	The Zacks Analyst Blog Highlights: Quidel, Halozyme Therapeutics, Teladoc Health, Acceleron Pharma and BioCryst Pharmaceuticals Zacks
08:30AM	Quidel Receives Emergency Use Authorization for QuickVue® SARS Rapid Antigen Test for COVID-19 Diagnosis Business Wire
08:24AM	4 Healthcare Stocks to Take Care of in 2021 to Boost Portfolio Zacks
07:10AM	Is Quidel (NASDAQ:QDEL) Using Too Much Debt? Simply Wall St.
Dec-17-20 05:50PM	Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know Zacks
Dec-14-20 02:39PM	Is QDEL A Good Stock To Buy Now? Insider Monkey
Dec-11-20 05:20AM	Bull of the Day: Quidel (QDEL) Zacks
Dec-10-20 06:00PM	Quidel Corporation CEO Douglas Bryant Named Executive of the Year in MedTech Dive Awards For 2020 Business Wire
11:34AM	The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic Zacks
Dec-09-20 08:07AM	4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021 Zacks
06:50AM	2 Solid Coronavirus Testing Stocks to Buy Now Motley Fool
Dec-06-20 06:24AM	3 Top Healthcare Stocks to Buy Right Now Motley Fool
Dec-05-20 06:17AM	New Coronavirus Tests Have These Diagnostics Companies Recalibrating Motley Fool

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ferenczy William J.	SVP, Cardio/Metabolic Unit	Mar 17	Option Exercise	16.60	4,601	76,390	12,506	Mar 19 07:55 PM
Ferenczy William J.	SVP, Cardio/Metabolic Unit	Mar 17	Sale	136.06	7,400	1,006,837	5,106	Mar 19 07:55 PM
Kroll Werner	SVP, R&D	Feb 24	Sale	173.71	5,283	917,734	8,119	Feb 24 07:53 PM
Kroll Werner	SVP, R&D	Feb 23	Sale	166.30	4,835	804,058	13,402	Feb 24 07:53 PM
Kroll Werner	SVP, R&D	Feb 22	Option Exercise	43.54	12,784	556,674	31,021	Feb 24 07:53 PM
BRYANT DOUGLAS C	President & CEO	Feb 22	Buy	165.30	5,000	826,500	495,807	Feb 22 07:40 PM
Kroll Werner	SVP, R&D	Feb 22	Sale	164.11	12,784	2,097,955	18,237	Feb 24 07:53 PM
POLAN MARY LAKE PH D	Director	Dec 01	Sale	192.25	11,000	2,114,797	24,329	Dec 03 07:32 PM
POLAN MARY LAKE PH D	Director	Nov 06	Sale	284.17	3,000	852,505	35,329	Nov 06 07:19 PM
SLACIK CHARLES P	Director	Nov 05	Option Exercise	20.82	4,009	83,467	15,224	Nov 06 07:16 PM
SLACIK CHARLES P	Director	Nov 05	Sale	282.46	4,009	1,132,388	11,215	Nov 06 07:16 PM
POLAN MARY LAKE PH D	Director	Oct 23	Option Exercise	21.63	27,188	588,142	38,329	Oct 27 07:37 PM
POLAN MARY LAKE PH D	Director	Oct 12	Sale	275.83	11,743	3,239,015	11,141	Oct 14 07:26 PM
Strobeck Matthew	Director	Sep 03	Buy	155.63	400	62,254	38,145	Sep 04 07:09 PM
Strobeck Matthew	Director	Sep 02	Buy	166.65	7,300	1,216,511	37,745	Sep 04 07:09 PM
BRYANT DOUGLAS C	President & CEO	Aug 31	Buy	174.99	5,000	874,965	455,823	Sep 01 06:05 PM
Abney Michael Donald Jr.	SVP - Distribution	Aug 20	Option Exercise	34.14	2,582	88,143	9,216	Aug 24 12:03 PM
Abney Michael Donald Jr.	SVP - Distribution	Aug 20	Sale	250.00	2,582	645,500	6,634	Aug 24 12:03 PM
Abney Michael Donald Jr.	SVP - Distribution	Aug 19	Option Exercise	35.87	5,610	201,215	12,244	Aug 24 12:03 PM
Abney Michael Donald Jr.	SVP - Distribution	Aug 19	Sale	250.00	5,610	1,402,500	6,634	Aug 24 12:03 PM
BRYANT DOUGLAS C	President & CEO	Aug 11	Buy	234.12	5,000	1,170,600	450,823	Aug 11 08:38 PM
BUECHLER KENNETH F	Director	Aug 03	Option Exercise	14.43	7,800	112,554	67,624	Aug 05 08:26 PM
STEWARD RANDALL J	Chief Financial Officer	Aug 03	Option Exercise	18.46	21,166	390,657	24,014	Aug 05 08:33 PM
Michael Edward L.	Director	Aug 03	Buy	288.12	3,500	1,008,404	6,434	Aug 05 08:32 PM
STEWARD RANDALL J	Chief Financial Officer	Aug 03	Sale	286.31	21,166	6,060,126	2,848	Aug 05 08:33 PM
Kroll Werner	SVP, R&D	Aug 03	Sale	287.48	2,072	595,650	4,599	Aug 05 08:28 PM
BUECHLER KENNETH F	Director	Aug 03	Sale	289.22	7,800	2,255,946	59,824	Aug 05 08:26 PM
BRYANT DOUGLAS C	President & CEO	Jun 11	Buy	160.33	5,000	801,670	445,823	Jun 12 05:53 PM
Kroll Werner	SVP, R&D	May 27	Option Exercise	0.00	4,376	0	8,975	May 27 07:54 PM
Kroll Werner	SVP, R&D	May 22	Option Exercise	20.46	68,152	1,394,422	72,751	May 27 07:54 PM
Kroll Werner	SVP, R&D	May 22	Sale	174.44	68,152	11,888,149	4,599	May 27 07:54 PM
Bujarski Robert Joseph	SVP, NA Comm Ops & Gen Counsel	May 20	Sale	189.41	20,000	3,788,282	13,383	May 22 07:59 PM
Abney Michael Donald Jr.	SVP - Distribution	May 18	Option Exercise	17.95	15,970	286,675	15,432	May 20 08:02 PM
BORKAR RATAN S	SVP, Intl Comm Operations	May 18	Option Exercise	31.88	16,332	520,699	27,171	May 20 08:07 PM
STEWARD RANDALL J	Chief Financial Officer	May 18	Sale	185.35	20,000	3,707,040	2,848	May 20 08:11 PM
BORKAR RATAN S	SVP, Intl Comm Operations	May 18	Sale	192.82	28,312	5,459,113	524	May 20 08:07 PM
Abney Michael Donald Jr.	SVP - Distribution	May 18	Sale	198.46	15,970	3,169,387	6,634	May 20 08:02 PM
SLACIK CHARLES P	Director	May 15	Option Exercise	0.00	549	0	11,352	May 18 08:16 PM
BUECHLER KENNETH F	Director	May 15	Option Exercise	0.00	1,842	0	59,824	May 18 08:06 PM
WIDDER KENNETH J	Director	May 14	Option Exercise	0.00	2,100	0	14,416	May 18 08:21 PM
Strobeck Matthew	Director	May 14	Option Exercise	0.00	2,100	0	7,399	May 18 08:19 PM
BUECHLER KENNETH F	Director	May 14	Option Exercise	0.00	2,100	0	57,982	May 18 08:06 PM
SLACIK CHARLES P	Director	May 14	Option Exercise	0.00	2,100	0	10,803	May 18 08:16 PM
SCHULER JACK W	Director	May 14	Option Exercise	0.00	2,100	0	3,103,249	May 18 08:14 PM
POLAN MARY LAKE PH D	Director	May 14	Option Exercise	0.00	2,100	0	22,884	May 18 08:12 PM
ORDONEZ KATHY	Director	May 14	Option Exercise	0.00	1,856	0	1,856	May 18 08:10 PM
Michael Edward L.	Director	May 14	Option Exercise	0.00	2,100	0	2,934	May 18 08:08 PM
POLAN MARY LAKE PH D	Director	May 11	Sale	204.27	6,700	1,368,630	20,784	May 12 08:01 PM
BUECHLER KENNETH F	Director	May 11	Sale	200.00	5,000	1,000,000	55,882	May 13 08:01 PM
BUECHLER KENNETH F	Director	May 05	Option Exercise	13.25	10,449	138,449	60,882	May 07 08:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience